252 related articles for article (PubMed ID: 15819668)
21. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; van Drimmelen H; David B; Lelie N; De Micco P
Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
[TBL] [Abstract][Full Text] [Related]
22. Highly sensitive TaqMan RT-PCR assay for detection and quantification of both lineages of West Nile virus RNA.
Tang Y; Anne Hapip C; Liu B; Fang CT
J Clin Virol; 2006 Jul; 36(3):177-82. PubMed ID: 16675298
[TBL] [Abstract][Full Text] [Related]
23. Update: West Nile virus screening of blood donations and transfusion-associated transmission--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(13):281-4. PubMed ID: 15071426
[TBL] [Abstract][Full Text] [Related]
24. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors.
Tobler LH; Stramer SL; Lee SR; Baggett D; Wright D; Hirschkorn D; Walsh I; Busch MP
Vox Sang; 2005 Nov; 89(4):201-7. PubMed ID: 16262752
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.
Bouchardeau F; Girault A; Razer A; Servant-Delmas A; Mercier M; Laperche S
Transfusion; 2006 Dec; 46(12):2047-52. PubMed ID: 17176315
[TBL] [Abstract][Full Text] [Related]
26. Collaborative study to evaluate a working reagent for West Nile virus RNA detection by nucleic acid testing.
Saldanha J; Shead S; Heath A; Drebot M;
Transfusion; 2005 Jan; 45(1):97-102. PubMed ID: 15647024
[TBL] [Abstract][Full Text] [Related]
27. West Nile virus infections projected from blood donor screening data, United States, 2003.
Busch MP; Wright DJ; Custer B; Tobler LH; Stramer SL; Kleinman SH; Prince HE; Bianco C; Foster G; Petersen LR; Nemo G; Glynn SA
Emerg Infect Dis; 2006 Mar; 12(3):395-402. PubMed ID: 16704775
[TBL] [Abstract][Full Text] [Related]
28. In vitro evaluation of the protective role of human antibodies to West Nile virus (WNV) produced during natural WNV infection.
Rios M; Daniel S; Dayton AI; Wood O; Hewlett IK; Epstein JS; Caglioti S; Stramer SL
J Infect Dis; 2008 Nov; 198(9):1300-8. PubMed ID: 18771407
[TBL] [Abstract][Full Text] [Related]
29. Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors.
Orton SL; Stramer SL; Dodd RY
Transfusion; 2006 Feb; 46(2):272-7. PubMed ID: 16441606
[TBL] [Abstract][Full Text] [Related]
30. Nucleic acid testing for west nile virus RNA in plasma enhances rapid diagnosis of acute infection in symptomatic patients.
Tilley PA; Fox JD; Jayaraman GC; Preiksaitis JK
J Infect Dis; 2006 May; 193(10):1361-4. PubMed ID: 16619182
[TBL] [Abstract][Full Text] [Related]
31. West Nile virus among blood donors in the United States, 2003 and 2004.
Stramer SL; Fang CT; Foster GA; Wagner AG; Brodsky JP; Dodd RY
N Engl J Med; 2005 Aug; 353(5):451-9. PubMed ID: 16079368
[TBL] [Abstract][Full Text] [Related]
32. West Nile virus infection in blood donors in the New York City area during the 2010 seasonal epidemic.
Francis RO; Strauss D; Williams JD; Whaley S; Shaz BH
Transfusion; 2012 Dec; 52(12):2664-70. PubMed ID: 22486471
[TBL] [Abstract][Full Text] [Related]
33. West Nile virus in 2006 and 2007: the Canadian Blood Services' experience.
O'Brien SF; Scalia V; Zuber E; Hawes G; Alport EC; Goldman M; Fearon MA
Transfusion; 2010 May; 50(5):1118-25. PubMed ID: 20051051
[TBL] [Abstract][Full Text] [Related]
34. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
[TBL] [Abstract][Full Text] [Related]
35. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
36. Associations between West Nile virus infection and symptoms reported by blood donors identified through nucleic acid test screening.
Custer B; Kamel H; Kiely NE; Murphy EL; Busch MP
Transfusion; 2009 Feb; 49(2):278-88. PubMed ID: 19389211
[TBL] [Abstract][Full Text] [Related]
37. Transmission of West Nile virus through blood transfusion in the United States in 2002.
Pealer LN; Marfin AA; Petersen LR; Lanciotti RS; Page PL; Stramer SL; Stobierski MG; Signs K; Newman B; Kapoor H; Goodman JL; Chamberland ME;
N Engl J Med; 2003 Sep; 349(13):1236-45. PubMed ID: 14500806
[TBL] [Abstract][Full Text] [Related]
38. Rapid and accurate in vitro assays for detection of West Nile virus in blood and tissues.
Zhang W; Wu J; Li Y; Li F; Njoo H
Transfus Med Rev; 2009 Apr; 23(2):146-54. PubMed ID: 19304115
[TBL] [Abstract][Full Text] [Related]
39. Transfusion-associated transmission of West Nile virus, United States 2003 through 2005.
Montgomery SP; Brown JA; Kuehnert M; Smith TL; Crall N; Lanciotti RS; Macedo de Oliveira A; Boo T; Marfin AA;
Transfusion; 2006 Dec; 46(12):2038-46. PubMed ID: 17176314
[TBL] [Abstract][Full Text] [Related]
40. A case series of inactivated Japanese encephalitis virus vaccination associated with positive West Nile virus blood donor screening nucleic acid tests.
Drews SJ; Makowski K; Wood H; Dimitrova K; Yan MTS; Young D; Skeate R; Ng M; Hawes G; Fearon M; Bigham M
Transfusion; 2020 May; 60(5):1097-1103. PubMed ID: 32154927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
